PE20070180A1 - Compuestos de bencilpiperazina como agonistas del receptor gpr38 - Google Patents
Compuestos de bencilpiperazina como agonistas del receptor gpr38Info
- Publication number
- PE20070180A1 PE20070180A1 PE2006000888A PE2006000888A PE20070180A1 PE 20070180 A1 PE20070180 A1 PE 20070180A1 PE 2006000888 A PE2006000888 A PE 2006000888A PE 2006000888 A PE2006000888 A PE 2006000888A PE 20070180 A1 PE20070180 A1 PE 20070180A1
- Authority
- PE
- Peru
- Prior art keywords
- phenyl
- methyl
- piperidinamine
- piperazinyl
- fluorophenyl
- Prior art date
Links
- IQXXEPZFOOTTBA-UHFFFAOYSA-N 1-benzylpiperazine Chemical class C=1C=CC=CC=1CN1CCNCC1 IQXXEPZFOOTTBA-UHFFFAOYSA-N 0.000 title abstract 2
- 101001132878 Homo sapiens Motilin receptor Proteins 0.000 title abstract 2
- 102100033818 Motilin receptor Human genes 0.000 title abstract 2
- 239000000556 agonist Substances 0.000 title abstract 2
- -1 3 -FLUOROPHENYL Chemical class 0.000 abstract 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 abstract 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- 210000000936 intestine Anatomy 0.000 abstract 2
- ABKBSWVRNXDREE-IBGZPJMESA-N 1-[4-(4-fluoroanilino)piperidin-1-yl]-2-[4-[[(3s)-3-methylpiperazin-1-yl]methyl]phenyl]ethanone Chemical compound C1CN[C@@H](C)CN1CC(C=C1)=CC=C1CC(=O)N1CCC(NC=2C=CC(F)=CC=2)CC1 ABKBSWVRNXDREE-IBGZPJMESA-N 0.000 abstract 1
- HXXABQAEGBRHAX-BGYRXZFFSA-N 2-[4-[[(3r,5s)-3,5-dimethylpiperazin-1-yl]methyl]phenyl]-1-[4-(4-fluoroanilino)piperidin-1-yl]ethanone Chemical compound C1[C@@H](C)N[C@@H](C)CN1CC(C=C1)=CC=C1CC(=O)N1CCC(NC=2C=CC(F)=CC=2)CC1 HXXABQAEGBRHAX-BGYRXZFFSA-N 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
SE REFIERE A COMPUESTOS DE BENCILPIPERAZINA DE FORMULA (I), EN DONDE A ES FENILO O HETEROARILO DE 6 MIEMBROS OPCIONALMENTE SUSTITUIDO CON, ALQUILO O ALCOXI(C1-C4); R1 Y R2 SON INDEPENDIENTEMENTE H O ALQUILO(C1-C4); R3 ES FENILO O HETEROARILO DE 5 A 6 MIEMBROS OPCIONALMENTE SUSTITUIDO; X ES (CR4R5)n; n ES 1 O 2; Y ES NH, O O CH2; R4 Y R5 SON INDEPENDIENTEMENTE H Y ALQUILO(C1-C4); LOS CARBONOS C* DE LA PIPERAZINA TIENEN LA CONFIGURACION 3R,5S. SON PREFERIDOS: 1-[(4-{[(3R,5S)-3,5-DIMETIL-1-PIPERAZINIL]METIL}FENIL)ACETIL]-N-(4-FLUOROFENIL)-4-PIPERIDINAMINA, N-(3-FLUOROFENIL)-1-[(4-{[(3S)-3-METIL-PIPERAZINIL]METIL}FENIL)ACEIL]-4-PIPERIDINAMINA, N-(4-FLUOROFENIL)-1-[(4-{[(3S)-3-METIL-1-PIPERAZINIL]METIL}-FENIL)ACETIL]-4-PIPERIDINAMINA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON AGONISTAS PARCIAL O TOTAL DEL RECEPTOR GPR38 (RECEPTOR ACOPLADO A PROTEINA G), Y SON UTILES PARA EL TRATAMIENTO DE TRASTORNOS GASTROINTESTINALES ASOCIADOS CON HOPOMOTILIDAD, TAL COMO TRANSTORNOS FUNCIONALES DEL INTESTINO, DISPEPSIA FUNCIONAL O SINDROME DE INTESTINO IRRITABLE
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0515381A GB0515381D0 (en) | 2005-07-26 | 2005-07-26 | Compounds |
| GB0611469A GB0611469D0 (en) | 2006-06-09 | 2006-06-09 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20070180A1 true PE20070180A1 (es) | 2007-04-25 |
Family
ID=37560776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000888A PE20070180A1 (es) | 2005-07-26 | 2006-07-24 | Compuestos de bencilpiperazina como agonistas del receptor gpr38 |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US8536182B2 (es) |
| EP (2) | EP2441763A1 (es) |
| JP (1) | JP4938777B2 (es) |
| KR (1) | KR101281435B1 (es) |
| AR (1) | AR054508A1 (es) |
| AU (1) | AU2006274212B2 (es) |
| BR (1) | BRPI0613987A2 (es) |
| CA (1) | CA2616513C (es) |
| CR (1) | CR9722A (es) |
| CY (1) | CY1113257T1 (es) |
| DK (1) | DK1907374T3 (es) |
| EA (1) | EA014061B1 (es) |
| EG (1) | EG26235A (es) |
| ES (1) | ES2390812T3 (es) |
| HR (1) | HRP20120833T1 (es) |
| IL (1) | IL188854A (es) |
| JO (1) | JO2747B1 (es) |
| MA (1) | MA29723B1 (es) |
| MX (1) | MX2008001211A (es) |
| MY (1) | MY150098A (es) |
| NO (1) | NO340489B1 (es) |
| NZ (1) | NZ565062A (es) |
| PE (1) | PE20070180A1 (es) |
| PL (1) | PL1907374T3 (es) |
| PT (1) | PT1907374E (es) |
| SI (1) | SI1907374T1 (es) |
| TW (1) | TWI376375B (es) |
| WO (1) | WO2007012479A2 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0611907D0 (en) | 2006-06-15 | 2006-07-26 | Glaxo Group Ltd | Compounds |
| SI1907374T1 (sl) * | 2005-07-26 | 2012-11-30 | Glaxo Group Ltd | Derivati benzilpiperazina uporabni za zdravljenje gastrointestinalnih motenj |
| GB0524814D0 (en) * | 2005-12-05 | 2006-01-11 | Glaxo Group Ltd | Compounds |
| NZ570078A (en) | 2006-01-27 | 2011-10-28 | Ms Science Corp | Piperidine and piperazine derivatives |
| MX2009000110A (es) | 2006-06-28 | 2009-01-23 | Glaxo Group Ltd | Derivados de piperazinilo utiles en el tratamiento de enfermedades mediadas por el receptor grp38. |
| GB0723317D0 (en) | 2007-11-28 | 2008-01-09 | Glaxo Group Ltd | Compounds |
| KR101575703B1 (ko) | 2009-02-27 | 2015-12-10 | 라퀄리아 파마 인코포레이티드 | 모틸린 수용체에 대해 작용제 활성을 가진 옥시인돌 유도체 |
| JP2013518085A (ja) | 2010-02-01 | 2013-05-20 | ノバルティス アーゲー | ＣＲＦ−１受容体アンタゴニストとしてのピラゾロ［５，１ｂ］オキサゾール誘導体 |
| AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
| JP5748777B2 (ja) | 2010-02-02 | 2015-07-15 | ノバルティス アーゲー | Ｃｒｆ受容体アンタゴニストとしてのシクロヘキシルアミド誘導体 |
| CN113292485B (zh) * | 2021-06-08 | 2023-10-27 | 河南大学 | 苄基哌嗪脲类trpv1拮抗和mor激动双靶点药物及制备方法和应用 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5385912A (en) | 1991-03-08 | 1995-01-31 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Multicyclic tertiary amine polyaromatic squalene synthase inhibitors |
| TW355711B (en) | 1992-11-04 | 1999-04-11 | Chugai Pharmaceutical Co Ltd | Erythromycin derivatives |
| JP3449766B2 (ja) | 1993-11-19 | 2003-09-22 | 中外製薬株式会社 | モチリンアンタゴニスト |
| US5593994A (en) | 1994-09-29 | 1997-01-14 | The Dupont Merck Pharmaceutical Company | Prostaglandin synthase inhibitors |
| JP3901239B2 (ja) | 1996-03-13 | 2007-04-04 | 大正製薬株式会社 | アリールアルカン誘導体 |
| US5965578A (en) | 1996-04-03 | 1999-10-12 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5734012A (en) | 1996-05-16 | 1998-03-31 | Ohmeda Pharmaceutical Products Division Inc. | Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity |
| DE19644195A1 (de) | 1996-10-24 | 1998-04-30 | Solvay Pharm Gmbh | 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| AU4968997A (en) | 1996-11-26 | 1998-06-22 | Chugai Seiyaku Kabushiki Kaisha | 13-membered ring macrolide compounds, medicine containing the same, and process for producing the same |
| US6060491A (en) | 1997-06-19 | 2000-05-09 | Dupont Pharmaceuticals | 6-membered aromatics as factor Xa inhibitors |
| JP3583928B2 (ja) * | 1997-08-15 | 2004-11-04 | 中外製薬株式会社 | フェネチルアミン誘導体 |
| US5972939A (en) | 1997-10-28 | 1999-10-26 | Ortho-Mcneil Pharmaceutical, Inc. | Cyclopentene derivatives useful as antagonists of the motilin receptor |
| DE19805822B4 (de) | 1998-02-13 | 2009-02-05 | Solvay Pharmaceuticals Gmbh | 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US6165985A (en) | 1998-02-13 | 2000-12-26 | Solvay Pharmaceuticals Gmbh | 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them |
| GB9804734D0 (en) | 1998-03-05 | 1998-04-29 | Pfizer Ltd | Compounds |
| CA2330251A1 (en) * | 1998-06-12 | 1999-12-16 | Merck & Co., Inc. | Cloning and identification of the motilin receptor |
| JP2000191700A (ja) * | 1998-12-28 | 2000-07-11 | Kyowa Hakko Kogyo Co Ltd | 持続型消化管運動ペプチド |
| US20020010184A1 (en) | 2000-02-18 | 2002-01-24 | Dinsmore Christopher J. | Inhibitors of prenyl-protein transferase |
| US20020052380A1 (en) | 2000-02-18 | 2002-05-02 | Dinsmore Christopher J. | Inhibitors of prenyl-protein transferase |
| US6423714B2 (en) | 2000-03-13 | 2002-07-23 | Ortho Mcneil-Pharmaceutical, Inc.. | Cyclohexene derivatives useful as antagonists of the motilin receptor |
| WO2001068622A1 (en) | 2000-03-13 | 2001-09-20 | Ortho-Mcneil Pharmaceutical, Inc. | Novel cyclobutene derivatives useful as antagonists of the motilin receptor |
| AU2001249144A1 (en) | 2000-03-13 | 2001-09-24 | Ortho-Mcneil Pharmaceutical, Inc. | Novel cyclopentene derivatives useful as antagonists of the motilin receptor |
| US6511980B2 (en) * | 2000-05-05 | 2003-01-28 | Ortho Mcneil Pharmaceutical, Inc. | Substituted diamine derivatives useful as motilin antagonists |
| US7102009B2 (en) | 2001-01-12 | 2006-09-05 | Amgen Inc. | Substituted amine derivatives and methods of use |
| EP1392679B1 (de) | 2001-05-10 | 2005-11-02 | Solvay Pharmaceuticals GmbH | Neue 1-amidomethylcarbonyl-piperidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US6977264B2 (en) | 2001-07-25 | 2005-12-20 | Amgen Inc. | Substituted piperidines and methods of use |
| PA8575901A1 (es) | 2002-07-18 | 2004-07-20 | Pfizer Prod Inc | Derivados de piperidina novedosos |
| US7223788B2 (en) | 2003-02-14 | 2007-05-29 | Sanofi-Aventis Deutschland Gmbh | Substituted N-aryl heterocycles, process for their preparation and their use as medicaments |
| AU2004261329B2 (en) * | 2003-07-31 | 2011-10-27 | Ocera Therapeutics, Inc. | Spatially-defined macrocyclic compounds useful for drug discovery |
| US7407941B2 (en) * | 2003-08-26 | 2008-08-05 | Pfizer, Inc. | N-desmethyl-N-substituted-11-deoxyerythromycin compounds |
| US7338954B2 (en) | 2003-09-17 | 2008-03-04 | Bristol-Myers Squibb Company | Compounds useful as motilin agonists and method |
| US7262195B2 (en) | 2003-09-17 | 2007-08-28 | Bristol-Myers Squibb Company | Compounds useful as motilin agonists and method |
| WO2005063720A1 (ja) | 2003-12-25 | 2005-07-14 | Nippon Shinyaku Co., Ltd. | アミド誘導体及び医薬 |
| WO2005077373A2 (en) | 2004-02-03 | 2005-08-25 | Astrazeneca Ab | Treatment of gastro-esophageal reflux disease (gerd) |
| WO2005077345A1 (en) | 2004-02-03 | 2005-08-25 | Astrazeneca Ab | Compounds for the treatment of gastro-esophageal reflux disease |
| WO2005077368A2 (en) | 2004-02-03 | 2005-08-25 | Astrazeneca Ab | Treatment of gastro-esophageal reflux disease (gerd) |
| CA2559285A1 (en) | 2004-03-18 | 2005-09-29 | Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
| US20070293539A1 (en) | 2004-03-18 | 2007-12-20 | Lansbury Peter T | Methods for the treatment of synucleinopathies |
| US20060106060A1 (en) | 2004-03-18 | 2006-05-18 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies (Lansbury) |
| US20050272722A1 (en) | 2004-03-18 | 2005-12-08 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
| JP2007529555A (ja) | 2004-03-18 | 2007-10-25 | ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド | シヌクレイノパチーを治療する方法 |
| PE20060315A1 (es) | 2004-05-24 | 2006-05-15 | Irm Llc | Compuestos de tiazol como moduladores de ppar |
| SE0401345D0 (sv) | 2004-05-25 | 2004-05-25 | Astrazeneca Ab | Therapeutic compounds: Pyridine as scaffold |
| GB0611907D0 (en) | 2006-06-15 | 2006-07-26 | Glaxo Group Ltd | Compounds |
| EP1902022A1 (en) | 2005-07-12 | 2008-03-26 | Glaxo Group Limited | Piperazine heteroaryl derivates as gpr38 agonists |
| SI1907374T1 (sl) * | 2005-07-26 | 2012-11-30 | Glaxo Group Ltd | Derivati benzilpiperazina uporabni za zdravljenje gastrointestinalnih motenj |
| GB0524814D0 (en) | 2005-12-05 | 2006-01-11 | Glaxo Group Ltd | Compounds |
| MX2009000110A (es) | 2006-06-28 | 2009-01-23 | Glaxo Group Ltd | Derivados de piperazinilo utiles en el tratamiento de enfermedades mediadas por el receptor grp38. |
| GB0723317D0 (en) | 2007-11-28 | 2008-01-09 | Glaxo Group Ltd | Compounds |
-
2006
- 2006-07-24 SI SI200631440T patent/SI1907374T1/sl unknown
- 2006-07-24 PT PT06776430T patent/PT1907374E/pt unknown
- 2006-07-24 EA EA200800421A patent/EA014061B1/ru not_active IP Right Cessation
- 2006-07-24 JO JO2006248A patent/JO2747B1/en active
- 2006-07-24 EP EP12150635A patent/EP2441763A1/en not_active Withdrawn
- 2006-07-24 NZ NZ565062A patent/NZ565062A/en not_active IP Right Cessation
- 2006-07-24 PE PE2006000888A patent/PE20070180A1/es not_active Application Discontinuation
- 2006-07-24 ES ES06776430T patent/ES2390812T3/es active Active
- 2006-07-24 CA CA2616513A patent/CA2616513C/en not_active Expired - Fee Related
- 2006-07-24 DK DK06776430.8T patent/DK1907374T3/da active
- 2006-07-24 US US11/996,650 patent/US8536182B2/en not_active Expired - Fee Related
- 2006-07-24 KR KR1020087002102A patent/KR101281435B1/ko not_active Expired - Fee Related
- 2006-07-24 BR BRPI0613987-6A patent/BRPI0613987A2/pt not_active Application Discontinuation
- 2006-07-24 PL PL06776430T patent/PL1907374T3/pl unknown
- 2006-07-24 MY MYPI20063524A patent/MY150098A/en unknown
- 2006-07-24 WO PCT/EP2006/007390 patent/WO2007012479A2/en not_active Ceased
- 2006-07-24 HR HRP20120833TT patent/HRP20120833T1/hr unknown
- 2006-07-24 JP JP2008523238A patent/JP4938777B2/ja not_active Expired - Fee Related
- 2006-07-24 AU AU2006274212A patent/AU2006274212B2/en not_active Ceased
- 2006-07-24 MX MX2008001211A patent/MX2008001211A/es active IP Right Grant
- 2006-07-24 EP EP06776430A patent/EP1907374B1/en not_active Not-in-force
- 2006-07-24 TW TW095126884A patent/TWI376375B/zh not_active IP Right Cessation
- 2006-07-25 AR ARP060103206A patent/AR054508A1/es not_active Application Discontinuation
-
2008
- 2008-01-17 IL IL188854A patent/IL188854A/en not_active IP Right Cessation
- 2008-01-20 EG EG2008010090A patent/EG26235A/en active
- 2008-01-25 MA MA30595A patent/MA29723B1/fr unknown
- 2008-02-11 CR CR9722A patent/CR9722A/es unknown
- 2008-02-26 NO NO20081014A patent/NO340489B1/no not_active IP Right Cessation
-
2012
- 2012-10-26 CY CY20121101022T patent/CY1113257T1/el unknown
-
2013
- 2013-08-05 US US13/959,018 patent/US20130317041A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20121010A1 (es) | Derivados de bencimidazol | |
| PE20090237A1 (es) | Derivados de sulfonamidas como inhibidores de los canales de sodio | |
| RU2389722C2 (ru) | Варианты имидазола в качестве модуляторов рецептора гамма-аминомасляной кислоты (gaba) для лечения желудочно-кишечных (жк) расстройств | |
| PE20080281A1 (es) | COMPUESTOS CINAMIDA COMO INHIBIDORES DE LA SINTESIS DEL ß-AMILOIDE 40 Y 42 | |
| NZ614305A (en) | Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases | |
| PE20070180A1 (es) | Compuestos de bencilpiperazina como agonistas del receptor gpr38 | |
| PE20080404A1 (es) | Derivados bencil-amino-piperidina como inhibidores de cetp | |
| PE20110684A1 (es) | Agonistas de los receptores de la melanocortina | |
| EA200870489A1 (ru) | Пиперидинилзамещённые пирролидиноны в качестве ингибиторов 11-бета-гидроксистероид дегидрогеназы 1 | |
| EA200901514A1 (ru) | Новая сольватная и кристаллическая форма производных карбамоилциклогексана | |
| PE20090620A1 (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen | |
| PE20090890A1 (es) | Compuestos derivados de 1-(2,3-dihidrobenzo[1,4]dioxin-2-ilmetil)azaciclos como antagonistas del suptipo adrenoreceptor alfa2c | |
| PE20090482A1 (es) | Derivados heterociclicos como antagonistas del receptor ccr2 | |
| PE20090240A1 (es) | Derivados heterociclicos sustituidos y su uso farmaceutico y composiciones | |
| AR061917A1 (es) | Compuesto analogo de piperidina, morfolina y pirrolidinilo, composicion farmaceutica que lo comprende y su uso para preparar un medicamento | |
| PE20090592A1 (es) | Nuevos derivados de piperazina-amida | |
| PE20091431A1 (es) | Compuestos derivados de azetidinas, su preparacion y su aplicacion en terapeutica | |
| PE20081703A1 (es) | Nuevos derivados triciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| MXPA05013772A (es) | 4-(aminometil)-piperidin benzamidas como antagonistas de 5ht4. | |
| PE20070490A1 (es) | Compuestos derivados de bencimidazol-2-ona sustituidos con piperidina como agonistas del receptor muscarinico m1 | |
| NO20084674L (no) | 1- [ (4-(benzoyl (metyl) amino] -3- (fenyl) butyl] azetidinderivater for behandling av gastrointestinale lidelser | |
| PE20090629A1 (es) | Pirazinas y piperidinas piperazinil sustituidas como antagonistas del receptor 5-ht7 | |
| NZ600266A (en) | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | |
| PE20091579A1 (es) | Derivados de sulfonamida sustituida | |
| PE20060770A1 (es) | Derivados de n-[(4,5-difenil-3-alquil-2-tienil)metil]amina como antagonistas de los receptores cannabinoides cb1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |